Phio Pharmaceuticals Corp. Gains 45.24%
Phio Pharmaceuticals Corp. (PHIO:NASDAQ) jumped higher at $0.61, a gain of 45.2%. On Fri, Jan 06, 2023, PHIO:NASDAQ hit a New 2-Week High of $0.61. The stock got featured on our News Catalysts scanner on Fri, Jan 06, 2023 at 04:51 PM in the 'BIOTECH' category. From Fri, Dec 23, 2022, the stock recorded 62.50% Up Days and 66.67% Green Days
The stock spiked on Fri, Jan 06, 2023 at $0.78 with a volume of 8M+.
About Phio Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.
Top 10 Gainers:
- Moolec Science SA (MLEC:NASDAQ), 258.47%
- Swvl Holdings Corp (SWVL:NASDAQ), 115.36%
- Spruce Biosciences Inc. (SPRB:NASDAQ), 93.6%
- MultiMetaVerse Holdings Ltd Ord (MMV:NASDAQ), 82%
- MedAvail Holdings Inc. (MDVL:NASDAQ), 80.19%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 77.78%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 53.72%
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 45.24%
- Oxbridge Re Holdings Limited (OXBR:NASDAQ), 43.51%
- CytomX Therapeutics, Inc. (CTMX:NASDAQ), 40.78%